Laying the Groundwork for COVID-19 Vaccines: Dr. Drew Weissman and mRNA Technology at Penn Medicine - YouTube
Genital Herpes Vaccine Is a Winner in Animals. Next Up: Testing on Humans - Be part of the knowledge - ReachMD
Uptake of herpes zoster vaccine linked to supply | ACP Internist
JCI - Trivalent nucleoside-modified mRNA vaccine yields durable memory B cell protection against genital herpes in preclinical models
Home | The Weissman Lab | Perelman School of Medicine at the University of Pennsylvania
World Immunization Week 2018 - Penn Medicine
New Genital Herpes Vaccine Candidate Provides Powerful Protection in Preclinical Tests - Penn Medicine
The Story Behind the mRNA COVID Vaccines | Dr. Drew Weissman and Dr. Katalin Kariko | Pfizer | COVID-19 mRNA vaccine pioneers Dr. Drew Weissman and Dr. Katalin Karikó have been awarded
Herpes vaccine is a winner in animals. Next up: Testing on humans.
Why 50+ People Should Get Vaccinated Against Shingles
COVID vaccine's mRNA technology also works for HIV vaccine - WHYY
Researcher with Type 1 Diabetes Is Behind the COVID-19 Vaccines
How vaccines may affect the cornea - EyeWorld
Genital Herpes News, Research
Dr. Drew Weissman on the exciting future of mRNA | Christie's
Messenger RNA vaccines: Now proven against coronavirus, the technology can do so much more | CNN
An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection | PLOS Pathogens
From foundational discoveries to profound impact | Penn Today
COVID-19 Vaccines, COPD, and Emphysema | Everyday Health
mRNA: Technology used to make Pfizer, Moderna COVID vaccines tested to treat HIV, cancer, more - 6abc Philadelphia
A new herpes vaccine leaves no trace of infection or disease | Penn Today
New HSV-2 Vaccine Uses mRNA to Treat Herpes in Mice | Penn Medicine
